# Safety and Immune Response of COVID-19 Vaccination in Patients With HIV Infection

> **NCT05043129** · — · UNKNOWN · sponsor: **The Second Affiliated Hospital of Chongqing Medical University** · enrollment: 200 (estimated)

## Conditions studied

- HIV Infections
- Covid19

## Interventions

- **BIOLOGICAL:** Biological/Vaccine: SARS-COV-2 VACCINE

## Key facts

- **NCT ID:** NCT05043129
- **Lead sponsor:** The Second Affiliated Hospital of Chongqing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-04
- **Primary completion:** 2022-03-01
- **Final completion:** 2022-09-04
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2021-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05043129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05043129, "Safety and Immune Response of COVID-19 Vaccination in Patients With HIV Infection". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05043129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*